Standard

An epigenome-wide association study of insulin resistance in African Americans. / Chilunga, Felix P.; Meeks, Karlijn A. C.; Henneman, Peter; Agyemang, Charles; Doumatey, Ayo P.; Rotimi, Charles N.; Adeyemo, Adebowale A.

In: Clinical epigenetics, Vol. 14, No. 1, 88, 14.07.2022.

Research output: Contribution to journalArticleAcademicpeer-review

Harvard

APA

Vancouver

Author

Chilunga, Felix P. ; Meeks, Karlijn A. C. ; Henneman, Peter ; Agyemang, Charles ; Doumatey, Ayo P. ; Rotimi, Charles N. ; Adeyemo, Adebowale A. / An epigenome-wide association study of insulin resistance in African Americans. In: Clinical epigenetics. 2022 ; Vol. 14, No. 1.

BibTeX

@article{2146a65e3d0942f1a11bb619eebecc4c,
title = "An epigenome-wide association study of insulin resistance in African Americans",
abstract = "Background: African Americans have a high risk for type 2 diabetes (T2D) and insulin resistance. Studies among other population groups have identified DNA methylation loci associated with insulin resistance, but data in African Americans are lacking. Using DNA methylation profiles of blood samples obtained from the Illumina Infinium{\textregistered} HumanMethylation450 BeadChip, we performed an epigenome-wide association study to identify DNA methylation loci associated with insulin resistance among 136 non-diabetic, unrelated African American men (mean age 41.6 years) from the Howard University Family Study. Results: We identified three differentially methylated positions (DMPs) for homeostatic model assessment of insulin resistance (HOMA-IR) at 5% FDR. One DMP (cg14013695, HOXA5) is a known locus among Mexican Americans, while the other two DMPs are novel—cg00456326 (OSR1; beta = 0.027) and cg20259981 (ST18; beta = 0.010). Although the cg00456326 DMP is novel, the OSR1 gene has previously been found associated with both insulin resistance and T2D in Europeans. The genes HOXA5 and ST18 have been implicated in biological processes relevant to insulin resistance. Differential methylation at the significant HOXA5 and OSR1 DMPs is associated with differences in gene expression in the iMETHYL database. Analysis of differentially methylated regions (DMRs) did not identify any epigenome-wide DMRs for HOMA-IR. We tested transferability of HOMA-IR associated DMPs from five previous EWAS in Mexican Americans, Indian Asians, Europeans, and European ancestry Americans. Out of the 730 previously reported HOMA-IR DMPs, 47 (6.4%) were associated with HOMA-IR in this cohort of African Americans. Conclusions: The findings from our study suggest substantial differences in DNA methylation patterns associated with insulin resistance across populations. Two of the DMPs we identified in African Americans have not been reported in other populations, and we found low transferability of HOMA-IR DMPs reported in other populations in African Americans. More work in African-ancestry populations is needed to confirm our findings as well as functional analyses to understand how such DNA methylation alterations contribute to T2D pathology.",
keywords = "African Americans, DNA methylation, Insulin resistance, Type 2 diabetes",
author = "Chilunga, {Felix P.} and Meeks, {Karlijn A. C.} and Peter Henneman and Charles Agyemang and Doumatey, {Ayo P.} and Rotimi, {Charles N.} and Adeyemo, {Adebowale A.}",
note = "Funding Information: Open Access funding is provided by the National Institutes of Health (NIH). This project was supported by the Intramural Research Program of the National Human Genome Research Institute of the National Institutes of Health (NIH) through the Center for Research on Genomics and Global Health (CRGGH). The CRGGH is also supported by the National Institute of Diabetes and Digestive and Kidney Diseases and the Office of the Director at the NIH (Z01HG200362). F.P.C. was supported by the European Foundation for the Study of Diabetes (EFSD) Albert Renold Travel Fellowship Programme. Publisher Copyright: {\textcopyright} 2022, The Author(s).",
year = "2022",
month = jul,
day = "14",
doi = "10.1186/s13148-022-01309-4",
language = "English",
volume = "14",
journal = "Clinical epigenetics",
issn = "1868-7075",
publisher = "Springer Verlag",
number = "1",

}

RIS

TY - JOUR

T1 - An epigenome-wide association study of insulin resistance in African Americans

AU - Chilunga, Felix P.

AU - Meeks, Karlijn A. C.

AU - Henneman, Peter

AU - Agyemang, Charles

AU - Doumatey, Ayo P.

AU - Rotimi, Charles N.

AU - Adeyemo, Adebowale A.

N1 - Funding Information: Open Access funding is provided by the National Institutes of Health (NIH). This project was supported by the Intramural Research Program of the National Human Genome Research Institute of the National Institutes of Health (NIH) through the Center for Research on Genomics and Global Health (CRGGH). The CRGGH is also supported by the National Institute of Diabetes and Digestive and Kidney Diseases and the Office of the Director at the NIH (Z01HG200362). F.P.C. was supported by the European Foundation for the Study of Diabetes (EFSD) Albert Renold Travel Fellowship Programme. Publisher Copyright: © 2022, The Author(s).

PY - 2022/7/14

Y1 - 2022/7/14

N2 - Background: African Americans have a high risk for type 2 diabetes (T2D) and insulin resistance. Studies among other population groups have identified DNA methylation loci associated with insulin resistance, but data in African Americans are lacking. Using DNA methylation profiles of blood samples obtained from the Illumina Infinium® HumanMethylation450 BeadChip, we performed an epigenome-wide association study to identify DNA methylation loci associated with insulin resistance among 136 non-diabetic, unrelated African American men (mean age 41.6 years) from the Howard University Family Study. Results: We identified three differentially methylated positions (DMPs) for homeostatic model assessment of insulin resistance (HOMA-IR) at 5% FDR. One DMP (cg14013695, HOXA5) is a known locus among Mexican Americans, while the other two DMPs are novel—cg00456326 (OSR1; beta = 0.027) and cg20259981 (ST18; beta = 0.010). Although the cg00456326 DMP is novel, the OSR1 gene has previously been found associated with both insulin resistance and T2D in Europeans. The genes HOXA5 and ST18 have been implicated in biological processes relevant to insulin resistance. Differential methylation at the significant HOXA5 and OSR1 DMPs is associated with differences in gene expression in the iMETHYL database. Analysis of differentially methylated regions (DMRs) did not identify any epigenome-wide DMRs for HOMA-IR. We tested transferability of HOMA-IR associated DMPs from five previous EWAS in Mexican Americans, Indian Asians, Europeans, and European ancestry Americans. Out of the 730 previously reported HOMA-IR DMPs, 47 (6.4%) were associated with HOMA-IR in this cohort of African Americans. Conclusions: The findings from our study suggest substantial differences in DNA methylation patterns associated with insulin resistance across populations. Two of the DMPs we identified in African Americans have not been reported in other populations, and we found low transferability of HOMA-IR DMPs reported in other populations in African Americans. More work in African-ancestry populations is needed to confirm our findings as well as functional analyses to understand how such DNA methylation alterations contribute to T2D pathology.

AB - Background: African Americans have a high risk for type 2 diabetes (T2D) and insulin resistance. Studies among other population groups have identified DNA methylation loci associated with insulin resistance, but data in African Americans are lacking. Using DNA methylation profiles of blood samples obtained from the Illumina Infinium® HumanMethylation450 BeadChip, we performed an epigenome-wide association study to identify DNA methylation loci associated with insulin resistance among 136 non-diabetic, unrelated African American men (mean age 41.6 years) from the Howard University Family Study. Results: We identified three differentially methylated positions (DMPs) for homeostatic model assessment of insulin resistance (HOMA-IR) at 5% FDR. One DMP (cg14013695, HOXA5) is a known locus among Mexican Americans, while the other two DMPs are novel—cg00456326 (OSR1; beta = 0.027) and cg20259981 (ST18; beta = 0.010). Although the cg00456326 DMP is novel, the OSR1 gene has previously been found associated with both insulin resistance and T2D in Europeans. The genes HOXA5 and ST18 have been implicated in biological processes relevant to insulin resistance. Differential methylation at the significant HOXA5 and OSR1 DMPs is associated with differences in gene expression in the iMETHYL database. Analysis of differentially methylated regions (DMRs) did not identify any epigenome-wide DMRs for HOMA-IR. We tested transferability of HOMA-IR associated DMPs from five previous EWAS in Mexican Americans, Indian Asians, Europeans, and European ancestry Americans. Out of the 730 previously reported HOMA-IR DMPs, 47 (6.4%) were associated with HOMA-IR in this cohort of African Americans. Conclusions: The findings from our study suggest substantial differences in DNA methylation patterns associated with insulin resistance across populations. Two of the DMPs we identified in African Americans have not been reported in other populations, and we found low transferability of HOMA-IR DMPs reported in other populations in African Americans. More work in African-ancestry populations is needed to confirm our findings as well as functional analyses to understand how such DNA methylation alterations contribute to T2D pathology.

KW - African Americans

KW - DNA methylation

KW - Insulin resistance

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85134112498&partnerID=8YFLogxK

U2 - 10.1186/s13148-022-01309-4

DO - 10.1186/s13148-022-01309-4

M3 - Article

C2 - 35836279

VL - 14

JO - Clinical epigenetics

JF - Clinical epigenetics

SN - 1868-7075

IS - 1

M1 - 88

ER -

ID: 25073096